Press Releases

Date Title
03/20/17
Summary ToggleNeothetics Announces Last Subject Enrolled in Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat Printer Friendly Version SAN DIEGO , March 20, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today announced completion of subject enrollment for its Phase 2 proof of concept trial, LIPO-202-CL-31, for the
03/16/17
Summary ToggleNeothetics to Provide a Business Update and Release Fourth Quarter 2016 Financial Results Thursday, March 23, 2017 Printer Friendly Version SAN DIEGO , March 16, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it will provide a business update and release its fourth quarter 2016 financial results before the market opens on Thursday, March 23 , 2017.  To receive Neothetics' press releases and other investor
12/23/16
Summary ToggleNeothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat Printer Friendly Version SAN DIEGO , Dec. 23, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced the initiation of the Phase 2 proof of concept trial, LIPO-202-CL-31, for LIPO-202 for the reduction of submental subcutaneous fat. “The initiation of our Phase 2 proof of concept trial for LIPO-202 for the
11/10/16
Summary ToggleNeothetics Provides Business Update and Reports Third Quarter 2016 Financial Results Printer Friendly Version SAN DIEGO , Nov. 10, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided a business update on its strategic initiatives and reported financial results for the third quarter 2016. “We continue to make good progress towards moving LIPO-202 back into the clinic,” said Ms. Martha J.
11/03/16
Summary ToggleNeothetics to Provide a Business Update and Release Third Quarter 2016 Financial Results Thursday, November 10, 2016 Printer Friendly Version SAN DIEGO , Nov. 03, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it will provide a business update and release its third quarter 2016 financial results before the market opens on Thursday,  November 10, 2016 . To receive Neothetics' press releases and other investor
08/11/16
Summary ToggleNeothetics Provides Business Update and Reports Second Quarter 2016 Financial Results Printer Friendly Version SAN DIEGO , Aug. 11, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided a business update on its strategic and operational initiatives and reported financial results for the second quarter 2016. “We are pleased with the progress made during the quarter and remain confident in
08/04/16
Summary ToggleNeothetics to Provide a Business Update and Release Second Quarter 2016 Financial Results Thursday, August 11, 2016 Printer Friendly Version SAN DIEGO , Aug. 04, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it will provide a business update and release its second quarter 2016 financial results before the market opens on Thursday,  August 11, 2016 . To receive Neothetics' press releases and other investor
05/12/16
Summary ToggleNeothetics Reports First Quarter 2016 Financial Results Printer Friendly Version SAN DIEGO , May 12, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today reported financial results and business progress for the first quarter 2016. First Quarter 2016 Highlights Neothetics plans to conduct a Phase 2 trial with a modified formulation of LIPO-202 in the third quarter of
05/05/16
Summary ToggleNeothetics to Release First Quarter 2016 Financial Results Printer Friendly Version SAN DIEGO , May 05, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that it will release its first quarter 2016 financial results before the market opens on May 12, 2016 .
04/06/16
Summary ToggleNeothetics to Present at the 15th Annual Needham Healthcare Conference Printer Friendly Version SAN DIEGO , April 06, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that Susan Knudson , Neothetics’ Chief Financial Officer, will present at the 15 th Annual Needham Healthcare Conference on Tuesday, April 12 th at 11:20 a.m.